The mission of Oncology Data Advisor is to provide the multidisciplinary team with expert insights into clinical best practices and research progress in cancer care.
…
continue reading
1
Esophageal Cancer Awareness Month: Treatment Advances and Tools for Maximizing Tolerability
18:29
18:29
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
18:29
This April, Oncology Data Advisor is raising awareness for Esophageal Cancer Awareness Month. In this interview, Oncology Data Advisor Editorial Board and Fellows Forum members Dr. Joseph Kalis, Dr. Matthew Hadfield, and Dr. Samuel Kareff discuss rising trends, treatment advances, and emerging management strategies for esophageal cancer, including …
…
continue reading
1
Linvoseltamab for Relapsed/Refractory Multiple Myeloma: Updates on LINKER-MM1 From AACR 2024
17:11
17:11
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
17:11
In this interview from the American Association for Cancer Research (AACR) 2024 Annual Meeting, Dr. Alankrita Taneja, third-year Hematology/Oncology Fellow at Roswell Park Cancer Institute and Oncology Data Fellows Forum Member, speaks with Dr. Sundar Jagannath, Professor of Medicine (Hematology and Medical Oncology) and Director of the Center of E…
…
continue reading
1
Improving Breast Cancer Surgical Outcomes With Lymphovenous Bypass
31:14
31:14
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
31:14
In this interview, Jason Mouabbi, MD, an Oncology Data Advisor Editorial Board Member and Assistant Professor in the Department of Breast Oncology at the University of Texas MD Anderson Cancer Center, sat down with Valerie Brutus, MD, FACS, a Breast Surgical Oncologist at St. Vincent's Medical Center of Hartford HealthCare, and Elizabeth Stirling C…
…
continue reading
Adolescent and Young Adult (AYA) Cancer Awareness Week, April 1 to 5, 2024, is a time to shine a spotlight on adolescent and young adult cancer patients and survivors. To commemorate the week, Lauren Ghazal, Megan-Claire Chase, and Allison Rosen, all members of the Oncology Data Advisor Editorial Board, sat down for a conversation to highlight the …
…
continue reading
1
Additional Advances in HER2-Positive Metastatic Colorectal Cancer Research: Christopher Lieu, MD
8:11
8:11
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
8:11
Dr. Christopher Lieu, Associate Director of Clinical Research at the University of Colorado Cancer Center and Vice Chair of the National Comprehensive Cancer Network (NCCN), is currently serving as chair of i3 Health's online activity, live webinar, and meeting series, Hitting the Target in HER2-Positive Metastatic Colorectal Cancer. With numerous …
…
continue reading
1
National Doctor’s Day With Samuel Kareff, MD, MPH, and Matthew Hadfield, DO
14:49
14:49
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
14:49
In this edition of the Oncology Data Fellows Forum in celebration of National Doctor's Day, Samuel Kareff, MD, MPH, and Matthew Hadfield, DO, discuss the highs and lows of working in this field and why it is important to take a moment to celebrate being a physician, your fellow physicians, and your patients.…
…
continue reading
1
Kidney Cancer Awareness Month: Discovering Clinical Strategies to Improve Outcomes
11:36
11:36
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
11:36
In this edition of Oncology Data Advisor celebrating Kidney Cancer Awareness Month Dr. Samuel Kareff, Dr. Waqas Haque, and Dr. Ulka Vaishampayan discuss the rising incidence of kidney cancer, warning signs and symptoms to look out for, environmental risk factors such as tobacco use, emerging treatment strategies using immunotherapy and adjuvant the…
…
continue reading
1
Fighting Hereditary Colorectal Cancer With Genetic Counseling: Catherine Skefos and Julie Moskowitz
24:12
24:12
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
24:12
In this edition of "Bridging the Gap in Cancer Care Through Genetic Counseling," Editorial Member Catherine Skefos speaks with her colleague Julie Moskowitz, MS, Genetic Counselor in the Gastrointestinal (GI) Center at MD Anderson Cancer Center, about hereditary aspects of colorectal cancer, how she counsels patients and families regarding their ri…
…
continue reading
1
International Women’s Day: Perspectives in Medicine, Nursing, and Fellowship
36:19
36:19
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
36:19
In this panel discussion in honor of International Women's Day on March 8, Dr. Richa Thakur, Dr. Nida Khan, Dr. Lauren Ghazal, and Dr. Gurbakhash Kaur discuss their perspectives as women in the fields of medicine and nursing, including their advice for negotiating, seeking mentors, overcoming imposter syndrome, building confidence, and making your …
…
continue reading
1
Additional Advances in aTTP Research and Clinical Trials With Spero Cataland, MD
8:47
8:47
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
8:47
Dr. Spero Cataland, Professor of Internal Medicine and the Benign Hematology Section Head at The Ohio State University, Wexner Medical Center, is currently serving as chair of i3 Health's free CME/NCPD activity and Hematology Fellows Lecture Series, Current Standards and New Directions in Treatment of Acquired Thrombotic Thrombocytopenic Purpura (a…
…
continue reading
1
Kidney Cancer Awareness Month: Spotlight on Genetic Counseling
21:23
21:23
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
21:23
In this interview for Kidney Cancer Awareness Month, Hiam Abdel-Salam, MS, CGC, speaks with Donika Saporito, MS, a Certified Genetic Counselor in the Genitourinary Center at MD Anderson Cancer Center, who provides an overview of genetic testing for hereditary kidney cancer syndromes and how she personally counsels the patients she sees.…
…
continue reading
1
Additional Advances in Soft Tissue Sarcoma With Brian Rubin, MD, PhD
10:39
10:39
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
10:39
Last year, Brian Rubin, MD, PhD, Chair of Pathology and Laboratory Medicine and the Chief of Diagnostics at the Cleveland Clinic, served as co-chair for i3 Health's continuing medical education (CME)–/nursing continuing professional development (NCPD)–approved virtual tumor board: Multidisciplinary Management of Advanced Soft Tissue Sarcoma, alongs…
…
continue reading
1
Multiple Myeloma Awareness Month 2024: What Patients Need to Know
58:07
58:07
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
58:07
For Multiple Myeloma Awareness Month this March, Oncology Data Advisor hosted a live panel discussion geared towards patients living with multiple myeloma. Dr. Rahul Banerjee, Dr. Alankrita Taneja, Dr. Richa Thakur, and Dr. Gurbakhash Kaur helped put the myriad of new developments in multiple myeloma treatment into perspective for patients and answ…
…
continue reading
1
Additional Advances in Esophagogastric Cancer Research and Clinical Trials With Jaffer Ajani, MD
7:18
7:18
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
7:18
Last year, Jaffer Ajani, MD, Professor in the Department of Gastrointestinal (GI) Medical Oncology at MD Anderson Cancer Center, served as co-chair of i3 Health's Virtual Tumor Board, Building Comprehensive Care Plans in Esophagogastric Cancers, along with Lei Zhao, MD, PhD, Assistant Professor of Pathology at Brigham and Women's Hospital, and Kell…
…
continue reading
1
Introduction to Genetic Counseling With Hiam Abdel-Salam, MS, CGC, and Catherine Skefos, MA, MS, CGC
38:35
38:35
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
38:35
In this first episode of Oncology Data Advisor’s new podcast series, “Bridging the Gap in Cancer Care Through Genetic Counseling,” Hiam Abdel-Salam and Catherine Skefos provide an introduction to genetic counseling, including how they entered the field, what they do on a day-to-day basis, scenarios in which patients should or should not consider me…
…
continue reading
1
Thirty Years in the Making: The Approval of Lifileucel for Metastatic Melanoma
9:42
9:42
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
9:42
Following the recent approval of lifileucel for unresectable or metastatic melanoma—the first cellular therapy to receive an approval for solid tumors—Matthew Hadfield, DO, member of the Oncology Data Advisor Fellows Forum and third-year Fellow at Brown University, sat down with Richard Carvajal, MD, Oncology Data Advisor Editorial Board Member and…
…
continue reading
1
International Women’s Day With Alankrita Taneja, Maria Badillo, Ulka Vaishampayan, and Morana Vojnic
25:03
25:03
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
25:03
In celebration of Women's Day on March 8, Oncology Data Advisor hosted a live panel discussion in which the women of our Editorial Board and Fellows Forum share what the day means to them, progress that has been made in female representation in leadership roles, continued obstacles to overcome, and the value of encouraging and mentoring other women…
…
continue reading
1
Discovering Research Advances in Mesothelioma: Samuel Kareff, MD, MPH, and Estela Rodriguez, MD, MPH
9:43
9:43
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
9:43
In this Fellows Forum interview, Dr. Samuel Kareff speaks with Dr. Estela Rodriguez, Clinical Research Lead of the Thoracic Site Disease Group at the University of Miami Sylvester Comprehensive Cancer Center, about recent research advances in mesothelioma, the emerging roles of immunotherapy and biomarker testing, and the importance of ensuring acc…
…
continue reading
1
Rare Disease Day 2024 With Rahul Banerjee, Matthew Hadfield, Joseph Kalis, and Nagashree Seetharamu
43:43
43:43
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
43:43
On Rare Disease Day on February 29, members of the Oncology Data Advisor Editorial Board and Fellows Forum hosted a live panel discussion focused on the rare diseases that they treat, including tireless efforts underway to develop novel treatment strategies, enhance quality of life, and improve outcomes for patients.…
…
continue reading
1
Exploring the Intersection of Emergency Medicine and Oncology With Joseph Oropeza and Joseph Kalis
20:25
20:25
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
20:25
In this interview, Joseph Kalis, PharmD, BCOP, introduces Joseph Oropeza, PharmD, BCCP, one of the newest Editorial Board members of Oncology Data Advisor. Dr. Oropeza shares what he does as an Emergency Medicine Pharmacist, the intersections of oncology and the emergency department, the steps he takes to manages oncologic emergencies, and the impo…
…
continue reading
1
Colorectal Cancer Awareness Month With Allison Rosen, MS, and Matthew Hadfield, DO
12:13
12:13
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
12:13
In honor of Colorectal Cancer Awareness Month this March, Allison Rosen, MS, and Matthew Hadfield, DO, members of the OncData Editorial Board and Fellows Forum, sat down to discuss their perspectives on the month from both the clinical and survivorship viewpoints, including efforts to advocate for increased clinical trial funding, recent updates in…
…
continue reading
1
Expanding Clinical Trial Access With Decentralization and Technology: Waqas Haque and Shaalan Beg
20:05
20:05
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
20:05
In this installment of Oncology Data Advisor's Exploring AI in Oncology series, Dr. Waqas Haque speaks with Dr. Shaalan Beg, an Adjunct Associate Professor at the University of Texas (UT) Southwestern, who is spearheading efforts to decentralize clinical trials in oncology and expand access for eligible patients. Dr. Beg describes the tools that ar…
…
continue reading
1
National Donor Day: How To Be the Match With Richa Thakur, MD, and Will Smith
9:57
9:57
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
9:57
On February 14, Oncology Data Advisor is celebrating National Donor Day and recognizing the contributions of individuals who have given organ and tissue donations for patients in need. In this interview, Fellows Forum member Dr. Richa Thakur has a conversation with Will Smith, a High School History Teacher, who gave an anonymous stem cell donation …
…
continue reading
1
Accelerated Approvals in Oncology: Benefits, Risks, and the Way Forward
30:03
30:03
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
30:03
In this interview, Dr. Jason Mouabbi, OncData Editorial Board Member and Breast Medical Oncologist at MD Anderson Cancer Center, speaks with Dr. Ross Maclean and Michael Glover about the debate surrounding accelerated FDA approvals, including their benefits, risks, and ways that physicians, patients, pharmaceutical companies, and the FDA can collab…
…
continue reading
1
National Cancer Prevention Month: Rising Trends and How to Combat Them
16:01
16:01
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
16:01
In honor of National Cancer Prevention Month 2024, members of the Oncology Data Advisor Editorial Board and Fellows Forum sat down for a panel discussion about the rising incidence of cancer diagnoses, factors contributing to them, and how to counsel patients in light of these emerging trends.i3 Health による
…
continue reading
1
Breaking Developments in Neuroendocrine Tumor Research: Dr. Samuel Kareff and Dr. Aman Chauhan
14:43
14:43
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
14:43
In this Fellows Forum interview, Samuel Kareff, MD, MPH, interviews Aman Chauhan, MD, Leader of the Neuroendocrine Tumor Program at the University of Miami, Sylvester Comprehensive Cancer Center, about how he became involved in neuroendocrine cancer research, the latest developments in novel therapies, and the future of using radiopharmaceuticals a…
…
continue reading
1
World Cancer Day 2024 with Oncology Data Advisor
24:06
24:06
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
24:06
In honor of World Cancer Day on February 4, members of the Oncology Data Advisor Fellows Forum and Editorial Board joined forces for a thought-provoking discussion about improving cancer care on a global scale, including treatment access, molecular testing, clinical trial diversity, and patient advocacy worldwide.…
…
continue reading
1
Gallbladder and Bile Duct Cancer Awareness Month: Improving Screening and Treatment Options
10:53
10:53
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
10:53
In honor of Gallbladder and Bile Duct Cancer Awareness Month this February, Fellows Forum members Dr. Waqas Haque and Dr. Matthew Hadfield sat down for a discussion on the challenges in diagnosis of gallbladder and bile duct cancers and the importance of genetic sequencing for making targeted treatments available for patients.…
…
continue reading
1
National Cancer Prevention Month With Stephen Freedland and William Aronson
21:20
21:20
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
21:20
In honor of National Cancer Prevention Month, Dr. Stephen Freedland, Urologist at Cedars-Sinai Medical Center and Oncology Data Advisor Editorial Board Member, sat down with Dr. William Aronson, Professor of Urology at the University of California, Los Angeles (UCLA) and Chief of Urologic Oncology at the West Los Angeles Veterans Affairs (VA) Medic…
…
continue reading
1
Highlights of Multiple Myeloma Research Presented at ASH With Urvi Shah, MD
16:13
16:13
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
16:13
At the recent American Society of Hematology (ASH) Annual Meeting, numerous updates were presented with the potential to impact practice in relapsed/refractory multiple myeloma. While at the meeting, Urvi Shah, MD, Assistant Attending in the Myeloma Service at Memorial Sloan Kettering Cancer Center, shares some of most significant highlights of the…
…
continue reading
1
Streamlining the Pathology Workflow Through AI: Waqas Haque and Leif Honda of TriMetis
21:04
21:04
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
21:04
This second episode of Oncology Data Advisor's podcast series, Exploring Artificial Intelligence in Oncology, features Leif Honda, Chief Innovation Officer at TriMetis, a digital pathology company focused on improving patient outcomes by accelerating human tissue-based research, development, and testing. Dr. Waqas Haque, member of the Oncology Data…
…
continue reading
1
Capivasertib for PIK3CA/AKT1/PTEN–Altered Breast Cancer With Jason Mouabbi, MD, and Carlos Doti, MD
14:13
14:13
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
14:13
Recently, the FDA granted approval to capivasertib in combination with fulvestrant for patients with hormone receptor–positive, human epidermal growth factor receptor 2 (HER2)–negative locally advanced or metastatic breast cancer with one or more PIK3CA/AKT1/PTEN alterations. In this interview, Editorial Board member Dr. Jason Mouabbi speaks with D…
…
continue reading
1
Patterns of Care With BTK Inhibitors for CLL/SLL in the Community Setting: David Andorsky, MD
6:34
6:34
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
6:34
At the recent American Society of Hematology (ASH) Annual Meeting in San Diego, Dr. David Andorsky, MD, a Clinical Hematologist and Medical Oncologist at the Rocky Mountain Cancer Centers in Boulder, Colorado, presented his research and observations regarding patterns of care with Bruton tyrosine kinase (BTK) inhibitors and the distribution of soci…
…
continue reading
1
Investigating Hypomethylating Agents for Myelodysplastic Syndromes With Amer Zeidan
8:42
8:42
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
8:42
Recently, at the American Society of Hematology (ASH) Annual Meeting, Amer Zeidan, MBBS, MHS, the Interim Chief of Hematologic Malignancies Division at the Yale Cancer Center, presented his abstract regarding an investigation of oral decitabine and cedazuridine versus intravenous/subcutaneous hypomethylating agents (HMA) for patients with myelodysp…
…
continue reading
1
Epcoritamab for FL: Matt Hadfield, Alankrita Taneja, Tahi Ahmadi, Jacqueline Nielsen
28:21
28:21
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
28:21
Recently, Genmab and AbbVie announced updated results of the phase 1/2 EPCORE™ NHL-1 clinical trial of epcoritamab (epco) for patients with relapsed/refractory follicular lymphoma. In this interview, Dr. Matthew Hadfield and Dr. Alankrita Taneja of the Oncology Data Advisor Fellows Forum speak with Dr. Tahi Ahmadi, Chief Medical Officer at Genmab, …
…
continue reading
1
Managing Acute Leukemias and Lymphomas When Patients Stay Local: Dipti Patel-Donnelly, MD
4:50
4:50
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
4:50
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many distinguished clinicians and patient advocates about their research presented at the meeting. Part 2 of this podcast series features exclusive conversations on nurse navigation to reduce socioeconom…
…
continue reading
1
Real-World Outcomes of Brexuctabtagene Autoleucel for B-Cell ALL: Evandro Bezerra, MD
5:38
5:38
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
5:38
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many distinguished clinicians and patient advocates about their research presented at the meeting. Part 2 of this podcast series features exclusive conversations on nurse navigation to reduce socioeconom…
…
continue reading
1
Nurse Navigation to Address Socioeconomic Disparities in ALL Treatment: Greg Knight, MD
9:57
9:57
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
9:57
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many distinguished clinicians and patient advocates about their research presented at the meeting. Part 2 of this podcast series features exclusive conversations on nurse navigation to reduce socioeconom…
…
continue reading
1
Exploring Revumenib for KMT2-Rearranged Acute Leukemias in the AUGMENT Trial: Ibrahim Aldoss, MD
8:05
8:05
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
8:05
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many distinguished clinicians and patient advocates about their research presented at the meeting. Part 2 of this podcast series features exclusive conversations on nurse navigation to reduce socioeconom…
…
continue reading
1
Utilizing ctDNA to Assess Survival With Odronextamab for FL and DLBCL: Jon Arnason, MD
4:52
4:52
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
4:52
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many distinguished clinicians and patient advocates about their research presented at the meeting. Part 2 of this podcast series features exclusive conversations on nurse navigation to reduce socioeconom…
…
continue reading
1
Investigating Talquetamab + Pomalidomide in the MonumenTAL-2 Study: Jeffrey Matous, MD
5:13
5:13
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
5:13
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many distinguished clinicians and patient advocates about their research presented at the meeting. Part 2 of this podcast series features exclusive conversations on nurse navigation to reduce socioeconom…
…
continue reading
1
Improving QOL in Multiple Myeloma With Bortezomib Dose Reduction: Rahul Banerjee and Gurbakhash Kaur
8:16
8:16
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
8:16
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many distinguished clinicians and patient advocates about their research presented at the meeting. Part 2 of this podcast series features exclusive conversations on nurse navigation to reduce socioeconom…
…
continue reading
1
Guiding Dietary Choices During Multiple Myeloma Treatment: Richa Parikh, MD
5:47
5:47
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
5:47
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many distinguished clinicians and patient advocates about their research presented at the meeting. Part 2 of this podcast series features exclusive conversations on nurse navigation to reduce socioeconom…
…
continue reading
1
Improving End-of-Life Care for Patients With AML Receiving Non-Curative Therapy: Richa Thakur, MD
9:34
9:34
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
9:34
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many distinguished clinicians and patient advocates about their research presented at the meeting. Part 2 of this podcast series features exclusive conversations on nurse navigation to reduce socioeconom…
…
continue reading
1
Coping With Psychological Distress Prior to Hematopoietic Cell Transplantation: Richard Newcomb, MD
10:17
10:17
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
10:17
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many distinguished clinicians and patient advocates about their research presented at the meeting. Part 2 of this podcast series features exclusive conversations on nurse navigation to reduce socioeconom…
…
continue reading
1
Investigating Odronextamab for R/R FL and DLBCL in the ELM-2 Study: Sabarish Ayyappan, MD
5:08
5:08
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
5:08
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many distinguished clinicians and patient advocates about their research presented at the meeting. Part 2 of this podcast series features exclusive conversations on nurse navigation to reduce socioeconom…
…
continue reading
1
Exploring Acalabrutinib ± Obinutuzumab for CLL in the ELEVATE-TN Study: Jeff Sharman, MD
5:03
5:03
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
5:03
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many distinguished clinicians and patient advocates about their research presented at the meeting. Part 2 of this podcast series features exclusive conversations on nurse navigation to reduce socioeconom…
…
continue reading
1
Highlights of Multiple Myeloma Research Presented at ASH 2023: Urvi Shah, MD
16:13
16:13
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
16:13
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many distinguished clinicians and patient advocates about their research presented at the meeting. Part 2 of this podcast series features exclusive conversations on nurse navigation to reduce socioeconom…
…
continue reading
1
Predicting Immune-Related Adverse Events Through Machine Learning With Dr. Ofer Sharon of OncoHost
33:06
33:06
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
33:06
In this first episode of Oncology Data Advisor’s new podcast series, “Exploring Artificial Intelligence in Cancer Care,” Dr. Waqas Haque and Dr. Matthew Hadfield of the OncData Fellows Forum engage in a discussion with Dr. Ofer Sharon, CEO of OncoHost. Dr. Sharon provides an overview of the clinical need for increased knowledge of patients’ probabi…
…
continue reading
1
Racial and Socioeconomic Disparities in the CLL Community Oncology Setting: Ira Zackon, MD
14:43
14:43
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
14:43
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many distinguished clinicians and patient advocates about their research presented at the meeting. Part 2 of this podcast series features exclusive conversations on patient advocacy groups in hematology,…
…
continue reading